Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02209038 · ClinicalTrials.gov registry record · NA
Choice Sets for Advance Directives
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 321
- Enrollment target
NCT02209038: Completed NA study, sponsored by University of Pennsylvania.
NCT02209038 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 321 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02209038, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 321 participants
- Enrollment target
Study Summary
There is a large gap between the care seriously ill patients want and the care they receive. Advance directives (ADs) offer an opportunity for patients to express specific end-of-life preferences to avoid unwanted care. As promising as ADs may be for improving the quality of care near the end of life, rates of AD completion remain low and previous efforts to encourage their completion have had limited success. Principles of behavioral economics, such as the effects of defaults and other framing effects, may offer a novel approach to bridge the gap in end-of-life care. The goal of this study is to test whether the framing effect of expanding choice sets can increase the completion of and specification of choices within advance directives.
Interventions
- BEHAVIORAL Expanded AD Choice
- BEHAVIORAL Expanded Life-sustaining Therapy Choice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02209038
The ClinicalTrials.gov registry entry for NCT02209038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 321 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Expanded AD Choice is the first listed.
NCT02209038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02209038 about?
NCT02209038 is a clinical study titled "Choice Sets for Advance Directives". There is a large gap between the care seriously ill patients want and the care they receive. Advance directives (ADs) offer an opportunity for patients to express specific end-of-life preferences to avoid unwanted care. As promising as ADs may be for improving the quality of care near the end of lif...
What is the current status of trial NCT02209038?
This trial is currently completed. It is a NA study. The enrollment target is 321 participants. The study started on 2014-07. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02209038?
The interventions under investigation include: Expanded AD Choice (BEHAVIORAL), Expanded Life-sustaining Therapy Choice (BEHAVIORAL).
Who is sponsoring clinical trial NCT02209038?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.